ROCKVILLE, Md.--(BUSINESS WIRE)--Innovative Biosensors, Inc. (IBI), a company developing rapid, ultra-sensitive tests to detect harmful pathogens for both the biodefense and clinical infectious disease markets, today announced the company’s selection for funding for a partnership proposal, with the A. James Clark School of Engineering at the University of Maryland, from The National Consortium for Measurement and Signatures Intelligence (MASINT) Research NCMR. The project, “Handheld Cell-Based BioSensor for Complex Samples,” will develop a miniaturized analysis system that could be used in industrial, environmental and clinical fields.
